Looking at what happened on the Nasdaq late yesterday and this morning is a great example of how easily a share that is strongly held by retail investors is manipulated by daily tactics rather than long term strategy based on intrinsic value.
All of the “new” information about the FDA questions re Remestemcel are more than appropriate and expected by anybody who understands the process and the novel approach represented by Mesobast. I would expect that the team at Mesoblast would have a red team green team process in place to prepare for this approval process.
Today will be owned by the traders and shooters, tomorrow is a new day.
I will accumulate!
MSB Trading - Aug 2020 on, page-819
-
- There are more pages in this discussion • 1,566 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |